Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy
about
Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsProgresses towards safe and efficient gene therapy vectorsCurrent and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsBarriers to inhaled gene therapy of obstructive lung diseases: A reviewUpdate in cystic fibrosis 2012.Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.Cystic fibrosis: a model system for precision medicine.Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.Emerging drugs for cystic fibrosis.Delivery of genes into the CF airway.Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.Genetic medicines for CF: Hype versus reality.rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.Roadmap for an early gene therapy for cystic fibrosis airway disease.Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework.Lessons learned from lung and liver in-vivo gene therapy: implications for the future
P2860
Q26747065-4E208A45-4C6A-4AFF-87C7-504B428158B1Q26781432-6A340080-65C7-47E3-840B-78B4B3BF95D5Q28077411-F5836E25-243C-4B2C-9460-8ED8A6C1A49AQ29248141-1EE6E0EC-A794-4E1B-9E82-2D4F6877018FQ33738510-435A6B3F-7B1D-40C5-A371-E1628F085F76Q35200182-FD808A60-82F5-4372-8226-76F304F73614Q35641704-0709D139-D14A-4240-A300-C3D0FEE73D54Q35659323-031B680F-B64E-4AB4-8EEF-A02C8F9A8796Q37097931-302A3168-0D06-4A8A-B5A6-136D21B8D3D6Q37265494-CA344E23-BC6B-4CFD-9B46-61C27BFF51D5Q37616952-202B0A9E-738D-497F-BBD3-9DE90EF23C14Q38121503-84120761-B0E1-4167-A8DF-A6F21DBB088AQ38183476-ABE1D392-6777-4022-A2C1-EC29767662A7Q38228513-960CC8CC-7C31-47C7-A4C5-822E67C1280CQ38325672-6ACE1BCE-78B4-4526-8011-D5E6D70A8ED1Q38818339-0F0BC869-47E5-4915-81DF-ABFF88FF9F85Q38949076-FE3BA12C-FAE1-4D56-BE9C-274F08E11272Q39166790-C0AEB134-B1BA-49BA-A8CB-7A2BF2F7E2F6Q41923573-4753CAF9-FD26-45B0-8039-568440A92EEBQ42199545-C97D24C2-3EAD-4C8C-8A02-9274AA536634Q45874266-9FF18986-CF22-43C5-99E1-CAAA92644C23Q57163666-592C49A2-D6A6-42BF-949F-26518E3D1D2C
P2860
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@ast
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@en
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@nl
type
label
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@ast
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@en
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@nl
prefLabel
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@ast
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@en
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@nl
P2093
P2860
P50
P1476
Assessment of F/HN-pseudotyped ...... t vector for lung gene therapy
@en
P2093
A Christopher Boyd
Angela Kerton
Cuixiang Meng
Eric W F W Alton
J Alastair Innes
Jane C Davies
Makoto Inoue
Mamoru Hasegawa
Mario Chan
P2860
P304
P356
10.1164/RCCM.201206-1056OC
P407
P577
2012-09-06T00:00:00Z